Combination of monoclonal antibody (Bevacizumab) and chemotherapy (FOLFIRI) in palliative treatment of metastatic adenocarcinoma of the small bowel (SBC): Case report and review of the literature

Archives of Medical Science

Volumn 5, Issue 4, 2009, Pages 647-651

  Stec, Rafał ^a   Grala, Bartłomiej ^a   Ma̧czewski, Michał ^b   Bodnar, Lubomir ^a   Zegadło, Arkadiusz ^a   Szczylik, Cezary ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Bevacizumab; Chemotherapy; FOLFIRI; Small bowel cancer

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ADULT; ANGIOGENESIS; ARTICLE; BILE REFLUX; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CASE REPORT; CHOLECYSTECTOMY; CHOLELITHIASIS; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ELECTIVE SURGERY; FEMALE; FOLLOW UP; GASTROSCOPY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPENIA; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PATIENT MONITORING; PROGNOSIS; SMALL INTESTINE ADENOCARCINOMA; SMALL INTESTINE CARCINOMA; TREATMENT RESPONSE;

EID: 75349092880     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Wojciechowska U, Didkowska J, Tarnowski W, KatońskiW. Cancer in Poland in 2004. The Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology. 2004 Chapter 12; 123.
2. Barclay TH, Schapira DV. Malignant tumors of the small intestine. Cancer 1983; 51: 878.
3. Green PH, Jabri B. Celiac disease and other precursors to small-bowel malignancy. Gastroenterol Clin North Am 2002; 31: 625-39.
4. Chow WH, Linet MS, Mclaughlin JK, Hsing AW, Chien HT, Blot WJ. Risk factors for small intestine cancer. Cancer Causes Control 1993; 4: 163-9.
5. Singhal N, Singhal D. Adjuvant chemotherapy for small intestine adenocarcinoma. Cochrane Database Syst Rev 2007; 3: CD005202.
6. Siedlecki P. Chemotherapy of Gastrointestinal Cancer. In: Cancer of digestive tract. Krawczyk M (ed.) [Polish]. PZWL, Warszawa 2001; 382.
7. Krzysztof G, Jeziorski A, Szawłowski W. Cancer of upper digestive tract and small bowel. In: Clinical oncology. Krzakowski M (ed.) [Polish]. Publishing house Borgis; Warszawa 2006; 866-7.
8. AJCC cancer staging handbook. Six edition. Small intestine 2002; 11: 119-23.
9. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of The small bowel. Presentation, prognostic factors and outcome of 217 patients. Cancer 2004; 101: 518-26.
10. Halfdanarson TR, Quevedo F, Mc Williams RR. Small bowel adenocarcinoma: A review of 491cases. J Clin Oncol 2006; 24: 4127.
11. Jigyasu D, Bedikian AY, Stroehlein JR. Chemotherapy for primary adenocarcinoma of the small bowel. Cancer 1984; 53: 23-5.
12. Fishman PN, Pond GR, Moore MJ, et al. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol 2006; 29: 225-31.
13. Locher CH, Malka D, Boige V, et al. Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology 2005; 69: 290-4.
14. Ellis LM. Mechanisms of action of bevacizumab as a component of therapy for metastatic colorectal cancer. Semin Oncol 2006; 33 (5 Suppl 10): S1-7.